Encoded Therapeutics website screenshot

Encoded Therapeutics

Encoded Therapeutics is a clinical-stage biopharmaceutical company developing next-generation gene therapies for neurological disorders, translating precision genetic science into transformative genetic medicines. Its Genetic Medicines Product Engine supports a pipeline led by ETX101, an investigational AAV gene therapy for SCN1A-positive Dravet Syndrome, alongside additional research programs. Backed by GV, Menlo Ventures, and SoftBank Vision Fund, the company is added to the API Evangelist network as a life-sciences profile. As a clinical-stage therapeutics company it publishes no public developer API, SDK, or developer portal; this profile captures its identity for the network.

Encoded Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Gene Therapy, Biotechnology, and Genetic Medicine.

2.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0
0 APIs
CompanyLife SciencesGene TherapyBiotechnologyGenetic MedicineNeurologyPharmaceuticals

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0
Composite quality — 2.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 0.0 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/encoded-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 1

The organization behind the API

Source (apis.yml)

apis.yml Raw ↑
aid: encoded-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/encoded-therapeutics.png
name: Encoded Therapeutics
description: Encoded Therapeutics is a clinical-stage biopharmaceutical company developing next-generation gene therapies
  for neurological disorders, translating precision genetic science into transformative genetic medicines. Its Genetic Medicines
  Product Engine supports a pipeline led by ETX101, an investigational AAV gene therapy for SCN1A-positive Dravet Syndrome,
  alongside additional research programs. Backed by GV, Menlo Ventures, and SoftBank Vision Fund, the company is added to
  the API Evangelist network as a life-sciences profile. As a clinical-stage therapeutics company it publishes no public developer
  API, SDK, or developer portal; this profile captures its identity for the network.
url: https://raw.githubusercontent.com/api-evangelist/encoded-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
- menlo-ventures
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Life Sciences
- Gene Therapy
- Biotechnology
- Genetic Medicine
- Neurology
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://encoded.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence